Robert Zivadinov researcher
Živadinov, Robert
Zivadinov, R.
VIAF ID: 311805721 (Personal)
Permalink: http://viaf.org/viaf/311805721
Preferred Forms
- 100 0 _ ‡a Robert Zivadinov ‡c researcher
- 100 1 _ ‡a Zivadinov, R.
- 100 1 _ ‡a Zivadinov, Robert
-
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Brain and spinal cord atrophy in multiple sclerosis, c2004: | |
Klinička neuroradiologija kralježnice i kralježničke moždine | |
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain? | |
Pharmacological treatment of early multiple sclerosis | |
Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis. | |
The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome | |
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. | |
Potential involvement of the extracranial venous system in central nervous system disorders and aging | |
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline | |
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. | |
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 | |
Progressive cerebral disease in lymphomatoid granulomatosis causes anterograde amnesia and neuropsychiatric disorder. | |
Prospective randomized trial of venous angioplasty in MS (PREMiSe) | |
Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses | |
Quantifying errors in flow measurement using phase contrast magnetic resonance imaging: comparison of several boundary detection methods | |
Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. | |
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study | |
Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping | |
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation. | |
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis | |
Recommendations for multimodal noninvasive and invasive screening for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency: a position statement of the International Society for Neurovascular Diseas | |
Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis. | |
Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment. | |
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study | |
Reliability and validity of neuropsychological screening and assessment strategies in MS. | |
Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients | |
Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature | |
Rijeka, Trst, Buffalo | |
Risk factors for and management of cognitive dysfunction in multiple sclerosis | |
Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers | |
The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to imaging | |
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants | |
Role of platelets in neuroinflammation: a wide-angle perspective | |
The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: an analytical study with case presentation. | |
Role of venoplasty for treatment of multiple sclerosis: value of open-label studies and surrogate treatment outcomes. | |
The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. | |
Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis | |
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis | |
A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS | |
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis | |
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study. | |
Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study | |
Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis | |
Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS | |
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS | |
Spoznajni poremećaji u multiploj sklerozi | |
Stable neuropsychiatric status in multiple sclerosis: a 3-year study. | |
Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease. | |
Susceptibility Weighted MRI in Rodents at 9.4 T. | |
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis. | |
Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study | |
Thalamic atrophy is associated with development of clinically definite multiple sclerosis | |
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study. | |
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations | |
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis | |
Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment? | |
Transcatheter aortic valve replacement: perioperative stroke and beyond | |
Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis? | |
Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis | |
[Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]. | |
Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects | |
Use of natalizumab in multiple sclerosis: current perspectives | |
The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study | |
Usporedba magnetske rezonancijske venografije i vaskularnog ultrazvuka u dijagnostici kronične cerebrospinalne venske insuficijencije u bolesnika s multiplom sklerozom i ispitanika bez neuroloških bolesti : doktorska disertacija | |
Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis. | |
Ventricular enlargement and mild cognitive impairment in early Parkinson's disease | |
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. |